Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rosenthal

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Chronicity Counts: The Impact of <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, and Coinfection in Cystic FibrosisMicaela Mossop, Jonathan Ish-Horowicz, Dominic Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathyIan D Davis, Lynette Kiers, Lachlan MacGregor, et al.
Thorax|January 15, 2011
Development of the bronchial epithelial reticular basement membrane: relationship to epithelial height and ageLemonia Tsartsali, Alison A Hislop, Karen McKay, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Thorax|June 3, 2026
Oxygen-enhanced MRI and multiple breath washout with Short extension reveal cystic fibrosis lung disease progression despite triple modulator therapyChristopher Short, Tom Semple, Mary Abkir, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
ESMO Open|July 16, 2020
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised studyMark Rosenthal, Paul M Clement, Mario Campone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisoneCharles J Ryan, Mark Rosenthal, Siobhan Ng, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Chronicity Counts: The Impact of <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, and Coinfection in Cystic FibrosisMicaela Mossop, Jonathan Ish-Horowicz, Dominic Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathyIan D Davis, Lynette Kiers, Lachlan MacGregor, et al.
Thorax|January 15, 2011
Development of the bronchial epithelial reticular basement membrane: relationship to epithelial height and ageLemonia Tsartsali, Alison A Hislop, Karen McKay, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Thorax|June 3, 2026
Oxygen-enhanced MRI and multiple breath washout with Short extension reveal cystic fibrosis lung disease progression despite triple modulator therapyChristopher Short, Tom Semple, Mary Abkir, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
ESMO Open|July 16, 2020
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised studyMark Rosenthal, Paul M Clement, Mario Campone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisoneCharles J Ryan, Mark Rosenthal, Siobhan Ng, et al.
Pageof 11